vimarsana.com
Home
Live Updates
Infection-Focused Barinthus Bios VTP-200 Data Underwhelming: Analyst Weighs On Mixed Perspectives : comparemela.com
Infection-Focused Barinthus Bio's VTP-200 Data Underwhelming: Analyst Weighs On Mixed Perspectives
On Friday, Barinthus Biotherapeutics plc (NASDAQ:BRNS), formerly Vaccitech plc, released topline final data from the APOLLO trial (...
Related Keywords
Nadege Pelletier ,
William Blair ,
Barinthus Biotherapeutics ,
Barinthus Bio ,
Nasdaq ,
Bill Enright ,
Chief Scientific Officer ,
comparemela.com © 2020. All Rights Reserved.